We examined whether bladder cancer cells contained activated PKCα by analyzing the phosphorylation of a PKCα-specific peptide substrate [22] using matrix-assisted laser desorption/ionization–time-of-flight mass spectrometry (MALDI-TOF MS). The gene discussed is PRKCA; the disease is urinary bladder cancer.